½ÃÀ庸°í¼­
»óǰÄÚµå
1595101

Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀå : »ýüÀç·á, À¯Çü, Á¦Ç° À¯Çüº° - ¼¼°è Àü¸Á(2025-2030³â)

Orthopedic Implants Market by Bio-Material (Ceramic Biomaterials, Metallic Biomaterials, Polymeric Biomaterials), Type (Ankle, Dental, Hip), Product Type - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 193 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀåÀº 2023³â¿¡ 567¾ï 1,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú½À´Ï´Ù. 2024³â¿¡´Â 599¾ï 2,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 5.74%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 838¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ Àü¸ÁÀÔ´Ï´Ù.

Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ®´Â ½Åü¿¡ ¿Ü°úÀûÀ¸·Î »ðÀÔµÇ¾î ¼Õ»óµÈ °üÀýÀ̳ª »À¸¦ ÁöÁöÇϰųª ´ëüÇÏ¿© ÀûÀýÇÑ Á¤·Ä, ¾ÈÁ¤¼º ¹× À̵¿¼ºÀ» ÃËÁøÇÏ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ®ÀÇ Çʿ伺Àº Àα¸ÀÇ °í·ÉÈ­, Á¤Çü¿Ü°ú ÁúȯÀÇ À¯º´·ü Áõ°¡, ¿Ü°ú ¼ö¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ¹ß»ýÇÕ´Ï´Ù. Àç°Ç ¼ö¼ú, ôÃß ÀÓÇöõÆ®, ¿Ü»ó ÀÓÇöõÆ®, ½ºÆ÷Ã÷ ºÎ»ó Ä¡·á µîÀÇ ºÐ¾ß¿¡ Àû¿ëµÇ°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃÖÁ¾ »ç¿ëÀÚ´Â º´¿ø, Á¤Çü¿Ü°ú Ŭ¸®´Ð, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC) µîÀ» Æ÷ÇÔÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀº ½ÅÈï±¹ÀÇ ±â¼ú ¹ßÀü°ú ÀÇ·á ÀÎÇÁ¶óÀÇ ¹ßÀü¿¡ Å©°Ô ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °ñ°üÀý¿°, ·ù¸¶Æ¼½º °üÀý¿°, °ñ´Ù°øÁõ°ú °°Àº ÁúȯÀÇ À¯ÇàÀ¸·Î ÀÎÇØ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀáÀçÀûÀÎ ºñÁî´Ï½º ±âȸ´Â »ýü ÀûÇÕ¼º ÀÓÇöõÆ®, °³ÀÎ ¸ÂÃãÇü ÀÇ·á, ȯÀÚÀÇ °æ°ú¸¦ ¸ð´ÏÅ͸µÇϰí ȸº¹À» ÃËÁøÇÏ´Â IoT ±â¼úÀÌ Àû¿ëµÈ ½º¸¶Æ® ÀÓÇöõÆ® °³¹ß¿¡¼­ ãÀ» ¼ö ÀÖ½À´Ï´Ù. ±â¾÷µéÀº AI¸¦ Ȱ¿ëÇØ ¼ö¼ú °á°ú¸¦ ¿¹ÃøÇÏ°í ºÐ¼®ÇÔÀ¸·Î½á ȯÀÚ ¸ÂÃãÇü ÀÓÇöõÆ® ¼³°è¸¦ ÃÖÀûÈ­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±×·¯³ª ÀÓÇöõÆ® ¹× ¼ö¼úÀÇ ³ôÀº ºñ¿ë, ¾ö°ÝÇÑ ±ÔÁ¦ Á¤Ã¥, °¨¿° ¹× ÀÓÇöõÆ® °ÅºÎ¹ÝÀÀ°ú °°Àº ¼ö¼ú ÈÄ ÇÕº´Áõ À§Çè µîÀÌ È¯ÀÚ Ã¤ÅÃÀ» ÀúÇØÇÒ ¼ö ÀÖ´Ù´Â Á¡ÀÌ ¹®Á¦Á¡À¸·Î ÁöÀûµÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ½ÃÀå °æÀïÀÌ Ä¡¿­ÇÏ¿© ¸¹Àº ±â¾÷µéÀÌ ±â¼ú ¿ìÀ§¿Í ½ÃÀå Á¡À¯À²À» ³õ°í °æÀïÇϰí ÀÖ½À´Ï´Ù. »ýºÐÇØ¼º ¹× Èí¼ö¼º Àç·áÀÇ Çõ½ÅÀº Àå±âÀûÀÎ ÇÕº´ÁõÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, 3D ÇÁ¸°ÆÃ¿¡ ´ëÇÑ ¿¬±¸´Â ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ´Â ¸ÂÃãÇü ÀÓÇöõÆ® Á¦ÀÛ¿¡ À¯¸ÁÇÕ´Ï´Ù. ½ÃÀå ¿ªÇÐÀº ±Þ¼ÓÇÑ ±â¼ú Çõ½Å°ú ÃÖ¼Ò Ä§½À ¼ö¼ú ¹× ³»±¸¼ºÀÌ ¶Ù¾î³­ Á¦Ç°¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼ö¿ä Áõ°¡·Î Ư¡ Áö¾îÁö´Â ¿ªµ¿ÀûÀÌ°í °æÀïÀÌ Ä¡¿­ÇÑ ½ÃÀåÀÔ´Ï´Ù. ¿¬±¸°³¹ß¿¡ ÅõÀÚÇÏ°í ¿¬±¸±â°ü°ú Çù·ÂÇÏ´Â ±â¾÷µéÀº ³ª³ë±â¼ú°ú »ýüÀç·á ºÐ¾ß¿¡¼­ ȹ±âÀûÀÎ ¹ßÀüÀ» ÀÌ·ê ¼ö ÀÖÀ¸¸ç, ÀÌ´Â ÇâÈÄ ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ȯÀÚ ´ÏÁî, ±ÔÁ¦ ¹× ±â¼ú µ¿ÇâÀ» ÀÌÇØÇÏ´Â °ÍÀº ±â¾÷ÀÌ °æÀï·ÂÀ» À¯ÁöÇÏ°í »õ·Î¿î ±âȸ¸¦ Ȱ¿ëÇÏ´Â µ¥ ÀÖ¾î ¸Å¿ì Áß¿äÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁØ ¿¬µµ(2023³â) 567¾ï 1,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2024³â) 599¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø ¿¬µµ(2030³â) 838¾ï 5,000¸¸ ´Þ·¯
CAGR(%) 5.74%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯È­Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ º¯È­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº Á¤º¸¿¡ ÀÔ°¢ÇÑ ÅõÀÚ °áÁ¤, Àü·«Àû ÀÇ»ç°áÁ¤, »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Æ÷ÂøÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Æ®·»µå¸¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª Àü¹Ý¿¡ °ÉÄ£ ´Ù¾çÇÑ À§ÇèÀ» ÁÙÀÏ ¼ö ÀÖÀ¸¸ç, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¹× ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • Á¤Çü¿Ü°ú ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í Ä¡·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁ³½À´Ï´Ù,
    • ±Ù°ñ°Ý°è Áúȯ Ä¡·áÀÇ ±â¼ú ¹ßÀü
    • Á¶±â ȸº¹, ÃÖ¼ÒÇÑÀÇ ÅëÁõ, ºñ¿ë È¿À²ÀûÀÎ Ä¡·á¿¡ ´ëÇÑ ´ÏÁî
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±â±¸ÀÇ ºñÈ¿À²¼º ¹× Á¦Á¶»óÀÇ ½Ç¼ö·Î ÀÎÇÑ Á¦Ç° ȸ¼ö ¹ß»ý
  • ½ÃÀå ±âȸ
    • ÀÇ·á½Ã¼³ °³¼±À¸·Î ÀÎÇÑ ½ÅÈï±¹¿¡¼­ÀÇ °¡´É¼º
    • ºÎ»óÀÌ ¸¹ÀÌ ¹ß»ýÇÏ´Â ½ºÆ÷Ã÷ Âü¿©¸¦ ´Ã¸®±â À§ÇÑ Á¤ºÎÀÇ Àû±ØÀû ³ë·Â
  • ½ÃÀå °úÁ¦
    • ½Å±Ô ÁøÀÔÀ» ½ÂÀÎÇÏ´Â ±î´Ù·Î¿î FDA ±ÔÁ¤

Portre's Five Forces: Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀå °ø·«À» À§ÇÑ Àü·«Àû µµ±¸

Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Portre's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ Ž»öÇÒ ¼ö ÀÖ´Â ¸íÈ®ÇÑ ¹æ¹ýÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂû·ÂÀ» ÅëÇØ ±â¾÷Àº °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ µµÀüÀ» ÇÇÇϰí, º¸´Ù °­·ÂÇÑ ½ÃÀå Æ÷Áö¼Å´×À» È®º¸ÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀåÀÇ ¿ÜºÎ ¿µÇâ·Â ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀο¡ ´ëÇÑ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇϸç, PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀû À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£µµ, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¼±Á¦ÀûÀÌ°í ´Éµ¿ÀûÀÎ ÀÇ»ç°áÁ¤À» ³»¸± Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü°ú °°Àº ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀïÀû À§Ä¡¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁßÈ­, ´ÜÆíÈ­ ¹× ÅëÇÕ Ãß¼¼¸¦ ÆÄ¾ÇÇÒ ¼ö ÀÖÀ¸¸ç, °ø±Þ¾÷ü´Â Ä¡¿­ÇÑ °æÀï ¼Ó¿¡¼­ ÀÚ½ÅÀÇ ÀÔÁö¸¦ °­È­ÇÒ ¼ö ÀÖ´Â Àü·«Àû ÀÇ»ç°áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ ÅëÂû·ÂÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀå¿¡¼­°ø±Þ¾÷ü ¼º°ú Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Á¤Çü¿Ü°ú ÀÓÇöõÆ® ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº º¥´õÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±â¹ÝÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ºÎÇÕÇÏ´Â Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ¸¸ç, 4°³ÀÇ »çºÐ¸éÀ¸·Î º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ¼¼ºÐÈ­ÇÏ¿© Àü·«Àû ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù. Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê¿Í ¼Ö·ç¼ÇÀ» ½Äº°ÇÒ ¼ö ÀÖ½À´Ï´Ù.

Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§ÇÑ Àü·« ºÐ¼® ¹× ±ÇÀå »çÇ×

Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀå Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ ÀÔÁö¸¦ °­È­ÇϰíÀÚ ÇÏ´Â ±â¾÷¿¡°Ô ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ¿ª·® ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ½Äº°ÇÏ°í °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ȯ°æÀÇ µµÀüÀ» ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖµµ·Ï ÁغñÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõµµ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀå¿¡¼­ÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù°¢È­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä ¹ßÀü, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú ¹ßÀü µîÀ» °ËÅäÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÷´Ü ±â¼ú, ¿¬±¸ °³¹ß Ȱµ¿ ¹× Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀÌ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖµµ·Ï ´ÙÀ½°ú °°Àº Áß¿äÇÑ Áú¹®¿¡ ´ëÇÑ ´äº¯µµ Á¦°øÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå Àü¸ÁÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹®, Áö¿ªÀº?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5.º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
    • °úÁ¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®
  • PESTLE ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀå : ¹ÙÀÌ¿À¼ÒÀ纰

  • ¼¼¶ó¹Í ¹ÙÀÌ¿À¼ÒÀç
  • ±Ý¼Ó ¹ÙÀÌ¿À¼ÒÀç
    • ÄÚ¹ßÆ® ÇÕ±Ý
    • ½ºÅ×Àθ®½º ½ºÆ¿
    • ƼŸ´½ ÇÕ±Ý
  • °íºÐÀÚ »ýüÀç·á

Á¦7Àå Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀå : À¯Çüº°

  • ¹ß¸ñ
  • Ä¡°ú
  • ¾ûµ¢ÀÌ
  • ¹«¸­
  • ôÃß
  • ¼Õ¸ñ ¹× ¾î±ú

Á¦8Àå Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀå : Á¦Ç° À¯Çüº°

  • Ä¡°ú ÀÓÇöõÆ®
    • Plate Form Dental Implants
    • Root Form Dental Implants
  • ¿À¼Ò¹ÙÀÌ¿À·ÎÁ÷½º
    • µ¿Á¾ À̽Ä
    • »ÀÇü¼º ´Ü¹éÁú
    • Å»¿° »À ¸ÅÆ®¸¯½º
    • Àΰø »À ´ëü¹°
    • °üÀý³» º¸Ãæ ¿ä¹ý Á¦Ç°
  • Àç°Ç °üÀý ġȯ¼ú
    • »çÁö
    • °í°üÀý ġȯ ÀÓÇöõÆ®
    • ½½°üÀý ġȯ ÀÓÇöõÆ®
  • ôÃß ÀÓÇöõÆ®
    • ¿îµ¿ º¸Á¸ Àåºñ/ºñÀ¶ÇÕ Àåºñ
      • Annulus Repair Devices
      • Artificial Disc Replacement Devices
      • Dynamic Stabilization Devices
      • Nuclear Disc Prostheses
    • ôÃß °íÁ¤ Àåºñ
      • °æÃß °íÁ¤ Àåºñ
      • Ãßü°£ °íÁ¤ Àåºñ
      • Èä¿äÃß µð¹ÙÀ̽º
    • ôÃß ¾Ð¹Ú °ñÀý Ä¡·á ±â±¸
      • dz¼± ôÃß ¼ºÇü¼ú¿ë µð¹ÙÀ̽º
      • ôÃß ¼ºÇü¼ú¿ë µð¹ÙÀ̽º
  • ¿Ü»ó

Á¦9Àå ¾Æ¸Þ¸®Ä«ÀÇ Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦10Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦11Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Á¤Çü¿Ü°ú¿ë ÀÓÇöõÆ® ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦12Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®, 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸®½ºÆ®

  • Amplitude SAS
  • Argomedical AG
  • Biotech GmbH
  • Biotechni
  • C2F Implants
  • Ceraver
  • CONMED Corporation
  • Corin Group PLC
  • GWS Surgicals LLP
  • Hipokrat A.S
  • Implants International
  • Limacorporate S.p.A.
  • Mathys AG Bettlach
  • Peter Brehm GmbH
  • Smith & Nephew PLC
  • Smith and Nephew PLC
  • Zimmer Biomet Holdings, Inc.
LSH

The Orthopedic Implants Market was valued at USD 56.71 billion in 2023, expected to reach USD 59.92 billion in 2024, and is projected to grow at a CAGR of 5.74%, to USD 83.85 billion by 2030.

Orthopedic implants are medical devices surgically inserted into the body to support or replace a damaged joint or bone, facilitating proper alignment, stability, and mobility. The necessity for orthopedic implants arises from an aging population, increasing prevalence of orthopedic disorders, and advancements in surgical procedures. They find application in areas such as reconstructive surgery, spinal implants, trauma implants, and sports injury treatments. Major end-users include hospitals, orthopedic clinics, and ambulatory surgical centers. The market growth is significantly influenced by technological advancements and rising healthcare infrastructure in emerging economies. Additionally, the prevalence of conditions such as osteoarthritis, rheumatoid arthritis, and osteoporosis boosts demand. Potential opportunities lie in developing biocompatible implants, personalized medicine, and smart implants equipped with IoT technology to monitor patient progress and enhance recovery. Companies can leverage AI for predictive analytics in surgical outcomes, thereby optimizing patient-specific implant designs. However, challenges include the high cost of implants and surgeries, stringent regulatory policies, and the risk of post-surgical complications, such as infections and implant rejection, which can deter patient adoption. Furthermore, market competition is intense, with numerous players vying for technological superiority and market share. Innovations in biodegradable and absorbable materials can reduce long-term complications, while research into 3D printing is promising for creating customized implants with improved patient outcomes. The orthopedic implants market is dynamic and competitive, characterized by rapid technological changes and growing consumer demand for minimally invasive procedures and durable products. Companies that invest in R&D and collaborate with research institutions can achieve breakthroughs in nanotechnology and biomaterials, which could drive future growth. Understanding patient needs, regulatory landscapes, and technological trends is crucial for companies to maintain a competitive edge and capitalize on emerging opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 56.71 billion
Estimated Year [2024] USD 59.92 billion
Forecast Year [2030] USD 83.85 billion
CAGR (%) 5.74%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Orthopedic Implants Market

The Orthopedic Implants Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in prevalence of orthopedic disorders and awareness about the treatment,
    • Technology advancements in the treatment of musculoskeletal disorders
    • Need for faster recovery, minimum pain, and cost-effective treatments
  • Market Restraints
    • Incidence of product recalls due to device inefficiency or manufacturing errors
  • Market Opportunities
    • Potential in the emerging economies due to improved healthcare facilities
    • Favorable government initiatives to increase participation in sports leading to a high incidence of injuries
  • Market Challenges
    • Stringent FDA regulations approving the entry of new players

Porter's Five Forces: A Strategic Tool for Navigating the Orthopedic Implants Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Orthopedic Implants Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Orthopedic Implants Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Orthopedic Implants Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Orthopedic Implants Market

A detailed market share analysis in the Orthopedic Implants Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Orthopedic Implants Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Orthopedic Implants Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Orthopedic Implants Market

A strategic analysis of the Orthopedic Implants Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Orthopedic Implants Market, highlighting leading vendors and their innovative profiles. These include Amplitude SAS, Argomedical AG, Biotech GmbH, Biotechni, C2F Implants, Ceraver, CONMED Corporation, Corin Group PLC, GWS Surgicals LLP, Hipokrat A.S, Implants International, Limacorporate S.p.A., Mathys AG Bettlach, Peter Brehm GmbH, Smith & Nephew PLC, Smith and Nephew PLC, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Orthopedic Implants Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Bio-Material, market is studied across Ceramic Biomaterials, Metallic Biomaterials, and Polymeric Biomaterials. The Metallic Biomaterials is further studied across Cobalt Alloy, Stainless Steel, and Titanium Alloy.
  • Based on Type, market is studied across Ankle, Dental, Hip, Knee, Spine, and Wrist & Shoulder.
  • Based on Product Type, market is studied across Dental Implants, Orthobiologics, Reconstructive Joint Replacements, Spinal Implants, and Trauma. The Dental Implants is further studied across Plate Form Dental Implants and Root Form Dental Implants. The Orthobiologics is further studied across Allograft, Bone Morphogenetic Protein, Demineralized Bone Matrix, Synthetic Bone Substitutes, and Viscosupplementation Products. The Reconstructive Joint Replacements is further studied across Extremities, Hip Replacement Implants, and Knee Replacement Implants. The Spinal Implants is further studied across Motion Preservation Devices/Non-Fusion Devices, Spinal Fusion Devices, and Vertebral Compression Fracture Devices. The Motion Preservation Devices/Non-Fusion Devices is further studied across Annulus Repair Devices, Artificial Disc Replacement Devices, Dynamic Stabilization Devices, and Nuclear Disc Prostheses. The Spinal Fusion Devices is further studied across Cervical Fixation Devices, Interbody Fusion Devices, and Thoracolumbar Devices. The Vertebral Compression Fracture Devices is further studied across Balloon Kyphoplasty Devices and Vertebroplasty Devices.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in prevalence of orthopedic disorders and awareness about the treatment,
      • 5.1.1.2. Technology advancements in the treatment of musculoskeletal disorders
      • 5.1.1.3. Need for faster recovery, minimum pain, and cost-effective treatments
    • 5.1.2. Restraints
      • 5.1.2.1. Incidence of product recalls due to device inefficiency or manufacturing errors
    • 5.1.3. Opportunities
      • 5.1.3.1. Potential in the emerging economies due to improved healthcare facilities
      • 5.1.3.2. Favorable government initiatives to increase participation in sports leading to a high incidence of injuries
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent FDA regulations approving the entry of new players
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Orthopedic Implants Market, by Bio-Material

  • 6.1. Introduction
  • 6.2. Ceramic Biomaterials
  • 6.3. Metallic Biomaterials
    • 6.3.1. Cobalt Alloy
    • 6.3.2. Stainless Steel
    • 6.3.3. Titanium Alloy
  • 6.4. Polymeric Biomaterials

7. Orthopedic Implants Market, by Type

  • 7.1. Introduction
  • 7.2. Ankle
  • 7.3. Dental
  • 7.4. Hip
  • 7.5. Knee
  • 7.6. Spine
  • 7.7. Wrist & Shoulder

8. Orthopedic Implants Market, by Product Type

  • 8.1. Introduction
  • 8.2. Dental Implants
    • 8.2.1. Plate Form Dental Implants
    • 8.2.2. Root Form Dental Implants
  • 8.3. Orthobiologics
    • 8.3.1. Allograft
    • 8.3.2. Bone Morphogenetic Protein
    • 8.3.3. Demineralized Bone Matrix
    • 8.3.4. Synthetic Bone Substitutes
    • 8.3.5. Viscosupplementation Products
  • 8.4. Reconstructive Joint Replacements
    • 8.4.1. Extremities
    • 8.4.2. Hip Replacement Implants
    • 8.4.3. Knee Replacement Implants
  • 8.5. Spinal Implants
    • 8.5.1. Motion Preservation Devices/Non-Fusion Devices
      • 8.5.1.1. Annulus Repair Devices
      • 8.5.1.2. Artificial Disc Replacement Devices
      • 8.5.1.3. Dynamic Stabilization Devices
      • 8.5.1.4. Nuclear Disc Prostheses
    • 8.5.2. Spinal Fusion Devices
      • 8.5.2.1. Cervical Fixation Devices
      • 8.5.2.2. Interbody Fusion Devices
      • 8.5.2.3. Thoracolumbar Devices
    • 8.5.3. Vertebral Compression Fracture Devices
      • 8.5.3.1. Balloon Kyphoplasty Devices
      • 8.5.3.2. Vertebroplasty Devices
  • 8.6. Trauma

9. Americas Orthopedic Implants Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Orthopedic Implants Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Orthopedic Implants Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amplitude SAS
  • 2. Argomedical AG
  • 3. Biotech GmbH
  • 4. Biotechni
  • 5. C2F Implants
  • 6. Ceraver
  • 7. CONMED Corporation
  • 8. Corin Group PLC
  • 9. GWS Surgicals LLP
  • 10. Hipokrat A.S
  • 11. Implants International
  • 12. Limacorporate S.p.A.
  • 13. Mathys AG Bettlach
  • 14. Peter Brehm GmbH
  • 15. Smith & Nephew PLC
  • 16. Smith and Nephew PLC
  • 17. Zimmer Biomet Holdings, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦